KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Debt Ratio (2020 - 2025)

Recursion Pharmaceuticals' Debt Ratio history spans 6 years, with the latest figure at 0.01 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 33.21% year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, down 33.21%, while the annual FY2025 figure was 0.01, 33.21% down from the prior year.
  • Debt Ratio reached 0.01 in Q4 2025 per RXRX's latest filing, down from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.04 in Q2 2024 to a low of 0.0 in Q4 2022.
  • Average Debt Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2024.
  • Peak YoY movement for Debt Ratio: crashed 97.82% in 2022, then surged 2208.58% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.0 in 2021, then fell by 26.3% to 0.0 in 2022, then surged by 128.57% to 0.0 in 2023, then skyrocketed by 984.57% to 0.02 in 2024, then plummeted by 33.21% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for RXRX's Debt Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.02 (Q2 2025).